First Victory in the Battle of Science and Technology to the Epidemic, Global Health Innovation and Entrepreneurship Project Collection from Today

On March 23, the leading group of the central government to COVID-19 made a new judgment on the current domestic situation of prevention and control: the transmission of the local epidemic situation in China (mainly in Wuhan) has been controlled basically, but the risk of sporadic pathology and local outbreak still exists. On the 58th day after closing Wuhan, we finally got the best news of the spring.

A week ago, a COVID-19 control system program – COVID-19 Prevention and Treatment Manual – Clinical Experience in the First Affiliated Hospital of Medicine School of Zhejiang University, imminently written by Jack Ma Foundation, Alibabacoin Foundation, Aliyun and the First Affiliated Hospital of Medicine School of Zhejiang University for other countries affected severely in the world, was officially released worldwide.

During the epidemic period, the cumulative cure rate of the First Affiliated Hospital of Medicine School of Zhejiang University reached 98%, and it has created a miracle of “three zeros”, i.e. “zero infection” for medical staff, “zero missed diagnosis” for suspected patients and “zero death” for confirmed patients through pioneering treatment and new technologies investment. It is learned that the experience of the First Affiliated Hospital of Medicine School of Zhejiang University has been spread abroad. The Edinburgh Royal Infirmary (UK) and Yale University (USA) have connected with the First Affiliated Hospital of Medicine School of Zhejiang University to learn from the “experience of the First Affiliated Hospital of Medicine School of Zhejiang University” and provide effective professional guidance for the local treatment work.

Concentrated scientific research results become an important driving force of medical technology innovation

The miracle is based on the technological advantage that the First Affiliated Hospital of Medicine School of Zhejiang University has been actively exploring in scientific and technological innovation and transformation for a long time. In the form of “Value of Chinese Hospital Science and Technology in 2019 (2018)” released at the end of 2019, the comprehensive ranking of the First Affiliated Hospital of Medicine School of Zhejiang University is in the fourth, the epidemiology and general surgery ranked the first, the digestive epidemiology ranked the second, and the haematology, emergency medicine, kidney disease, orthopedic surgery and psychiatry enter the national top 10.

In October 2019, the Innovation and Transformation Center of the First Affiliated Hospital of Medicine School of Zhejiang University, established and managed by the First Affiliated Hospital of Medicine School of Zhejiang University, was established in the Medical Port Town of Qiantang New District, Hangzhou. The innovation and transformation center focuses on the research of basis and translational medicine of new technology, new method and new application in the fields such as cell therapy, gene editing and innovative drug research and development, clinical diagnosis and innovative medical devices. Since its establishment, the transformation center has done a lot of work in talent construction, discipline team construction, platform construction, and mechanism and system construction in the transformation of scientific and technological achievements of the First Affiliated Hospital of Medicine School of Zhejiang University.

Hangzhou Medical Port Town, where the Innovation and Transformation Center of the First Affiliated Hospital of Medicine School of Zhejiang University is located, is the gateway of Hangzhou Biomedical Industry. At present, Hangzhou Medical Port Town has gathered all kinds of biological pharmaceutical enterprises 950, seven of ten large pharmaceutical companies such as Pfizer and Merck have settled down, wherein the production scale is near 50% of that of Hangzhou City, and the industrial chain, innovation chain, ecological chain, talent chain, capital chain and service chain with rich connotation have been formed, and it will escort the growth and development of innovative biomedical enterprises. Located at the heart of the Hangzhou Economic and Technological Development Zone, the first Hangzhou-level characteristic town is becoming a source of medical technology innovation, as opposed to the Boston Area of the United States.

It is known that Hangzhou Medicine Port Town creates a whole chain industry ecology covering early exploration, pre-clinical research, clinical trials, approval and marketing, drug production and marketing for the transformation of scientific and technological achievements by focusing 4 major fields, i.e. biological pharmaceutical, medical devices, biomedical engineering, and medical data. In addition, the specialized industrial development platform with the total scale of 1200000m3 under construction can provide the development space for the whole process of incubation, acceleration and industrialization.

From today, the global health and medical innovation and entrepreneurship project collection activity jointly sponsored by the Management Committee of Hangzhou Qiantang New District, Hangzhou Municipal Talent Office, Hangzhou Investment Promotion Bureau, and the First Affiliated Hospital of Medicine School of Zhejiang University and undertaken by Hangzhou Medical Port Town, Hangzhou Dachuang Town, Innovation and Transformation Center of the First Affiliated Hospital of Medicine School of Zhejiang University and Vcbeat.top, is launched officially.

Global health and medical innovation and entrepreneurship projects collection was officially launched

This activity invites a wide range of domestic and overseas medical institutions, medical research institutions, and university laboratory innovation projects at all levels, as well as various stages of health and medical innovation enterprises to sign up. We will select the finalist award, crested ibis award, white rhino award and other awards from the entries, and give innovation in different dimensions such as policy, technology, ecology, capital and brand.

First Victory in the Battle of Science and Technology to the Epidemic, Global Health Innovation and Entrepreneurship Project Collection from Today

The winner may receive comprehensive policy support and guarantee from Hangzhou and Qiantang New District, 11 innovative service platforms jointly built by Hangzhou Medical Port and famous universities around the world, technology enabling innovation projects, the public service platform of Innovation and Transformation Center of the First Affiliated Hospital of Medicine School of Zhejiang University, Clinical Trial Center of Hangzhou Medical Port of the First Affiliated Hospital of Medicine School of Zhejiang University, Biological Drug Research and Development of Hangzhou Medical Port, Zhejiang Medical Instrument Inspection Institute and other public service platforms, full chain ecological innovation projects, 5 billion yuan industrial mother fund, the top medical fund inside and outside the United Nations, as well as financial support, 100+ global first-tier media, and provision of media communication services and other rich resources matrix for the event.

Award

The contents of the awards are as follows:

Finalist award: for the projects that meet the application requirements and submit the application materials according to the requirements, there is no limit on the number of entries and each project will be awarded 2000 yuan.

Crested ibis award: for the projects recognized by the expert judge group, the project will be entitled to the landing policy of Hangzhou Qiantang New District: project start-up fund of 0.2-1 million yuan, rent subsidy of 0.2 million yuan, and there is no limit.

White rhino award: the projects approved by the expert group can enjoy the landing policy of Hangzhou Qiantang New District: up to 10 million project start-up support and research and development funding, up to 1000 square meters of space with 3 years rent support, the maximum loan amount of 10 million yuan with 2 years discount interest, up to 10 million yuan for accelerating entrepreneurship and development, and there is no limit. (Among them, according to 15% of the actual investment in financing, the maximum annual revenue of 5 million YUAN + 10 million yuan for the first time, and the maximum annual revenue of 5 million yuan).

Scan the code for more preferential policies: https://cdn.vcbeat.top/upload/forum/99/39/68/0c/GIPHI.pdf

Category of project participated

Clinical projects include but are not limited to:

Global medical workers, researchers and related high-level talents/teams who have good cross-integration projects with non-clinical medical specialties can sign up for the innovative research and development and transformation of clinical application or diagnosis and treatment technologies of difficult diseases.

Innovative project fields include but are not limited to:

The participant’s organization is a relevant innovation enterprise registered or to be registered in China, and the joint registration of scientific research institutions and enterprises is encouraged.

Medicine: nucleotide drugs, biotechnology therapy projects, protein drugs, biological products and other biomedical, chemical and pharmaceutical intermediates and bulk drug processes, pharmaceutical preparations, chemical drug research and development and production, planting and processing of traditional Chinese medicine, traditional Chinese Medicine decoction pieces, Chinese patent medicine and other Chinese medicine;

Medical devices: pathology, imaging, nuclear magnetic and other large medical equipment, cardiovascular implantation, orthopedic materials, ophthalmic materials, dental materials, stent implantation, interventional instruments, surgery and anesthesia supplies and other medical supplies, biochemical diagnosis, immune diagnosis, molecular diagnosis, POCT and other in vitro diagnosis;

Others: artificial intelligence, big data and other industrial types

Active process

Enrollment

Website: https://i.eqxiu.com/s/z4MSFHCj?eqrcode=1

Media Contact
Company Name: Chongqing Vcbeat Technology Co., Ltd.
Contact Person: Vivian Tseng
Email: Send Email
Phone: Chongqing
Country: China
Website: http://www.vcbeat.top


Posted

in

by

Tags: